Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NATA intends to build a case to design and construct a 'fit for purpose' oligonucleotide cGMP facility in the UK and, as a first step, the aim of this exercise is to scope that facility from the perspectives of cost, timelines and operations, and to build details around those criteria.
Additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
No supplier information available.